OFW
CLDX icon

Omnia Family Wealth’s Celldex Therapeutics CLDX Stock Holding History

Omnia Family Wealth’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2
Closed – – 727
2016
Q4 		$0 Buy
+2
New +$114 ﹤0.01% 745

Other funds holding CLDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KE
KLP Enterprises Branford, Connecticut $1.97M AUM
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Omnia Family Wealth's CLDX Position: Q1 2017 in Review

Omnia Family Wealth sold out of Celldex Therapeutics (CLDX) in Q1 2017, closing a stake of 2 shares.

Omnia Family Wealth first reported a position in CLDX in Q4 2016 and held it in 1 quarter. The position peaked at $0 in Q4 2016. 134 funds tracked by Wall St. Rank hold CLDX as of Q1 2017.

  • Omnia Family Wealth reported no remaining Celldex Therapeutics position as of Q1 2017 after selling out during the quarter.
  • Omnia Family Wealth sold 2 Celldex Therapeutics shares in Q1 2017.
  • Omnia Family Wealth first reported a position in Celldex Therapeutics in Q4 2016 and held it in 1 quarter.
  • Omnia Family Wealth's Celldex Therapeutics position peaked at $0 in Q4 2016.
  • 134 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q1 2017.

Based on Omnia Family Wealth's 13F filing for Q1 2017, filed 5 May 2017.